{
  "actions": [
    {
      "acted_at": "2011-12-08", 
      "committee": "Committee on Health, Education, Labor, and Pensions", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1972-112", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "112", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Ayotte, Kelly", 
      "sponsored_at": "2011-12-08", 
      "state": "NH", 
      "thomas_id": "02075", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2011-12-08", 
  "number": "1972", 
  "official_title": "A bill to amend the Food and Drug Administration's mission.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr3214-112", 
      "reason": "related"
    }
  ], 
  "short_title": "Food and Drug Administration Mission Reform Act of 2011", 
  "sponsor": {
    "district": null, 
    "name": "Coats, Daniel", 
    "state": "IN", 
    "thomas_id": "00209", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2011-12-08", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Food and Drug Administration (FDA)", 
    "Health", 
    "Health technology, devices, supplies", 
    "Licensing and registrations"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2011-12-08", 
    "text": "Food and Drug Administration Mission Reform Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to revise the mission of the Food and Drug Administration (FDA) to include establishment of a regulatory system that: (1) advances medical innovation by incorporating modern scientific tools, standards, and approaches; (2) protects the public health and enables patients to access novel products while promoting economic growth, innovation, competitiveness, and job creation among the industries regulated by the FFDCA; (3) is based on the best available science; (4) allows for public participation and an open exchange of ideas; (5) promotes predictability, allows flexibility, and reduces uncertainty; (6) identifies and uses the most innovative and least burdensome tools for achieving regulatory ends; (7) ensures that regulations are accessible, consistent, transparent, written in plain language, and easy to understand; (8) measures, and seeks to improve, the actual results of regulatory requirements; and (9) incorporates a patient-focused benefit-risk framework that accounts for varying degrees of risk tolerance."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Food and Drug Administration Mission Reform Act of 2011", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to amend the Food and Drug Administration's mission.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T21:20:25-05:00"
}